Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg

Outline of Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg

The purpose of this study to collect information on the safety, especially serious infections and malignancies, and efficacy of the long-term use of ORENCIA Intravenous Infusion 250mg in patients with rheumatoid arthritis.

Inclusion Criteria:

• Patients who are beginning to receive the treatment with ORENCIA Intravenous Infusion 250mg under the approved indications, dosage, and administration
• Have available HAQ data
• Have available DAS28-ESR or DAS28- CRP data
• Have no past or present history of malignancies
• Are expected to be followed up for 3 years